Cipla Europe NV G.L. Pharma GmbH S&D Pharma CZ, spol. s.r.o.
PolandAll drugs from this manufacturer
-
The medicine is used to prevent breathing disorders, such as asthma and chronic obstructive pulmonary disease (COPD). It helps maintain airway patency and reduces lung swelling and irritation.
Dosage form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 0.0725 mg fluticasone propionate 0.25 mg ATC: R03AK06
-
The medicine is used to prevent breathing disorders, such as asthma and chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 0.0725 mg fluticasone propionate 0.5 mg ATC: R03AK06